Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

17%(1 trials)

Phase Distribution

Ph phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

6(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 16 (100.0%)

Trials by Status

completed6100%

Recent Activity

0 active trials

Showing 5 of 6

completedphase_1

A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers

NCT00959426

completedphase_1

A Phase 1 Study To Estimate The Relative Bioavailability And Food Effect Of PF-04620110 In Healthy Adult Subjects

NCT01064492

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT01298518Phase 1

A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients

Completed

NCT01146327Phase 1

A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects

Completed

NCT01166217Phase 1

A Single Dose Study Of PF-04620110 In Healthy Subjects

Completed

NCT00959426Phase 1

A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers

Completed

NCT01064492Phase 1

A Phase 1 Study To Estimate The Relative Bioavailability And Food Effect Of PF-04620110 In Healthy Adult Subjects

Completed

NCT00799006Phase 1

A Single Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6